FindTrial
Sign In

The Role of Tailbindu Mutra Pariksha in Prognosis of Lung Cancer- An Observational Study.

Evaluation of Tailbindu Mutra Pariksha in Prognosis of Lung Cancer- An Observational Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075598
Enrollment
65
Registered
2024-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

None listed

Sponsors

All India Institute of Ayurverda New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) All grades of Lung cancer patients regardless gender, religion & economic status. 2) Age-18 to 58 years will be included.

Exclusion criteria

Exclusion criteria: 1) LungCancer patients suffering from diabetes, CKD, mental disorders, autoimmune diseases, tuberculosis. 2) Pregnant and lactating mothers suffering from lung cancer.

Design outcomes

Primary

MeasureTime frame
A standardized prognostic tool that can help in instant assessment of Lung Cancer which is simple, non-invasive and cost-effective technique.Timepoint: At Baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSachin Chiranjiv Shende

All India Institute of Ayurveda New Delhi

drsaritav@gmail.com9029765299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026